Loss of the mismatched human leukocyte antigen haplotype in two acute myelogenous leukemia relapses after haploidentical bone marrow transplantation with post-transplantation cyclophosphamide

Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide

(2015) S. R. McCurdy et al.   BLOOD

Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia

(2015) S. O. Ciurea et al.   BLOOD

Erratum: Modern approaches to HLA-haploidentical blood or marrow transplantation.

(2015) Christopher G. Kanakry et al.   Nature Reviews Clinical Oncology

DLI after haploidentical BMT with post-transplant CY

(2014) A Ghiso et al.   BONE MARROW TRANSPLANTATION

Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation

(2014) L Crucitti et al.   LEUKEMIA

HLA-Haploidentical Donor Lymphocyte Infusions for Patients with Relapsed Hematologic Malignancies after Related HLA-Haploidentical Bone Marrow Transplantation

(2013) Amer M. Zeidan et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Different mechanisms causing loss of mismatched human leukocyte antigens in relapsing t(6;11)(q27;q23) acute myeloid leukemia after haploidentical transplantation

(2012) Hiroya Tamaki et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Genomic Loss of Mismatched Human Leukocyte Antigen and Leukemia Immune Escape From Haploidentical Graft-Versus-Leukemia

(2012) Luca Vago et al.   SEMINARS IN ONCOLOGY

Clonal Evolution Including Partial Loss of Human Leukocyte Antigen Genes Favoring Extramedullary Acute Myeloid Leukemia Relapse After Matched Related Allogeneic Hematopoietic Stem Cell Transplantation

(2012) Friedrich Stölzel et al.   TRANSPLANTATION

Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation

(2009) Luca Vago et al.   NEW ENGLAND JOURNAL OF MEDICINE

HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

(2008) Leo Luznik et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION